Description
Methyl 2-cyanoisonicotinate is a high-purity, precise compound that meets the strict requirements for drug synthesis. Its high quality and consistency make it an integral part of the pharmaceutical companies and research institutions working on the development and production of topirastat.
This intermediate compound is the key starting material in the synthesis of topirastat. It undergoes a carefully controlled series of chemical reactions that ultimately produce the final pharmaceutical product. Therefore, the purity, stability, and reliability of methyl 2-cyanoisonicotinate are critical to ensuring the quality and efficacy of the final product.
Our methyl 2-cyanoisonicotinate is produced using advanced processes and state-of-the-art equipment to ensure its purity and quality. It undergoes rigorous testing and analysis to ensure that it meets the highest standards set by the pharmaceutical industry. As a result, our customers can be confident in the reliability and consistency of this important intermediate compound.
Choose Us
JDK owns the first-class production facilities and Quality management equipments, which assures the stable supply of API intermediates. Professional team assure R&D of the product. Against both, we are searching for CMO & CDMO in domestic and international market.